HindIII polymorphism in the DCC gene

Por Devilee, P., Van Vliet, M., Cho, K.R., Vogelstein, B.
Publicado em 1991

Microsatellite instability is uncommon in uterine serous carcinoma.

Por Tashiro, H., Lax, S. F., Gaudin, P. B., Isacson, C., Cho, K. R., Hedrick, L.
Publicado em 1997

p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis.

Por Tashiro, H., Isacson, C., Levine, R., Kurman, R. J., Cho, K. R., Hedrick, L.
Publicado em 1997

Neural toxicity induced by accidental intrathecal vincristine administration.

Por Kwack, E. K., Kim, D. J., Park, T. I., Cho, K. R., Kwon, I. H., Sohn, Y. K.
Publicado em 1999

p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix.

Por Kessis, T. D., Slebos, R. J., Han, S. M., Shah, K., Bosch, X. F., Muñoz, N., Hedrick, L., Cho, K. R.
Publicado em 1993

p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.

Por Slebos, R J, Lee, M H, Plunkett, B S, Kessis, T D, Williams, B O, Jacks, T, Hedrick, L, Kastan, M B, Cho, K R
Publicado em 1994

Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.

Por Kessis, T D, Slebos, R J, Nelson, W G, Kastan, M B, Plunkett, B S, Han, S M, Lorincz, A T, Hedrick, L, Cho, K R
Publicado em 1993

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.

Por Wu, T C, Guarnieri, F G, Staveley-O'Carroll, K F, Viscidi, R P, Levitsky, H I, Hedrick, L, Cho, K R, August, J T, Pardoll, D M
Publicado em 1995